Latest common stock for GMVD: $4.8M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for GMVD is $4.8M as of December 2022. That compares with $1.2M in the prior-year period — up 295.7% year over year. Investors often review this figure alongside G Medical Innovations Holdings Limited's historical trend and sector peers before judging valuation or financial health.
Over the past year, GMVD's common stock moved from $1.2M to $4.8M — a 295.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in G Medical Innovations Holdings Limited's operating scale or balance-sheet position.
A common stock figure of $4.8M for GMVD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting GMVD's common stock ($4.8M), review year-over-year change from $1.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack G Medical Innovations Holdings Limited's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.